J Obstet Gynaecol Can. 2021 Nov 27:S1701-2163(21)00835-5. doi: 10.1016/j.jogc.2021.11.009. Online ahead of print.
ABSTRACT
A quality assurance study was completed following the implementation of a standardized opioid prescribing and education protocol post cesarean delivery. The primary goal was to determine the need for a policy on postpartum opioid prescribing practices and whether the protocol worked. There was a decrease in the number of tablets provided post intervention and no statistically significant maternal or neonatal readmissions for suspected opioid toxicity or pain control. Combination prescribing of Tylenol 3 and/or tramadol and another opioid occurred in both groups. Our results show a need for concise guidelines regarding opioid prescribing following cesarean delivery.
PMID:34848352 | DOI:10.1016/j.jogc.2021.11.009